• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS ANGIODYNAMICS / BIO FLO; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS ANGIODYNAMICS / BIO FLO; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number H965440140
Device Problem Occlusion Within Device (1423)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/02/2016
Event Type  malfunction  
Manufacturer Narrative
As no lot number was provided, a ship history report (shr) was generated for item number (h965440140) in order to ascertain the last three lots shipped to the reporting hospital in the six months prior to the procedure date.The device history records for the lots obtained through the shr were reviewed for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The march 2016 angiodynamics complaint report was reviewed for the bioflo ports product family and the failure mode "occluded - removed." no adverse trend was indicated.The reported complaint description cannot be confirmed, nor can a root cause be identified, as no sample was returned for evaluation.Angiodynamics process controls in place for this device include 100% aspiration of port valve assemblies at qa incoming.Valve assemblies are then sent back to supplier to be assembled into ports.Pasv valve crack testing: valves are 100% tested for aspiration pressure prior to being assembled into port bodies, and port 100% hydrostatic air test (hat): valves are 100% tested for infusion pressure after being assembled to port bodies.
 
Event Description
Patient had a bioflo port placed less than a year ago.He responded well to his chemo, had completed his therapy, and was currently just maintaining the port.The infusion nurses were not able to flush it (occluded with an obvious clot), so they decided to send him back to dr.(b)(6) for the removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIODYNAMICS / BIO FLO
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer (Section G)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
Manufacturer Contact
law ryan
10 glens falls technical park
glens falls, NY 12801
5187424488
MDR Report Key5742130
MDR Text Key47962346
Report Number1317056-2016-00086
Device Sequence Number1
Product Code LJT
UDI-Device IdentifierH965440140
UDI-PublicH965440140
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K131694
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 06/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberH965440140
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/02/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-